SIRPA and neoplasm: SLAMF7 (signaling lymphocytic activation molecule family 7, also known as CRACC, CS1, and CD319) remarkably facilitates engulfment of a few hematopoietic tumor cells expressing SLAMF7 such as Raji during CD47-SIRPα blockade (45, 102).